Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

News
error: Content is protected !!
google.com, pub-8062812296869199, DIRECT, f08c47fec0942fa0